Could MS treatments be linked to decreased cancer risk?
Researchers also hypothesize that disease-modifying therapies for multiple sclerosis could also be linked to the decreased cancer risk. They believe this is possible because there are actually several disease-modifying multiple sclerosis drugs currently being studied for their potential anti-cancer properties. This includes a drug known as dimethyl fumarate, or more commonly referred to as Tecfidera. This is a multiple sclerosis disease-modifying drug that could potentially help people with colon cancer. Other drugs include Gilenya (fingolimod) and Aubagio (teriflunomide). Aubagio has been suggested to be useful in breast cancers that are negative markers of poor prognosis.